These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 4971962

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Non-coronary effects of coronary agents].
    Zhmurkin VP, Zamotaev IP, Troshina TF.
    Sov Med; 1977 Jan; (1):48-53. PubMed ID: 403615
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Comparative studies on the effect of coronary dilators on the coronary blood circulation in man].
    Hilger HH, Behrenbeck DW, Hellwig H, Wagner J.
    Arzneimittelforschung; 1970 Mar; 20():441-2. PubMed ID: 5468726
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Physiology of the coronary circulation as a basis for evaluation of coronary dilators].
    Lochner W.
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969 Mar; 263(1):127-44. PubMed ID: 4979631
    [No Abstract] [Full Text] [Related]

  • 32. [The effect of coronary dilator drugs on oxygen pressure and blood supply of the dog myocardium, normal and with coronary insufficiency].
    Kadatz R.
    Arch Kreislaufforsch; 1969 Mar; 58(3):263-93. PubMed ID: 4979382
    [No Abstract] [Full Text] [Related]

  • 33. [Coronary vasodilator agents].
    Nakamura Y.
    Kokyu To Junkan; 1974 Sep; 22(9):662. PubMed ID: 4475463
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Possibilities of coronary circulatory intensifications presented by carbocromene injection and venous perfusion].
    Faucon G, Evreux JC, Lavarenne J, Kofman J, Perrot E.
    Therapie; 1968 Sep; 23(5):1123-33. PubMed ID: 5703931
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Comparative evaluation of the vasodilating action of myotropic substances on pulmonary vessels].
    Zaslavskaia RM.
    Kardiologiia; 1967 Oct; 7(10):127-9. PubMed ID: 4974810
    [No Abstract] [Full Text] [Related]

  • 40. [Prevention of disorders of myocardial blood supply, caused by the stimulation of the cerebral cortex by pharmacologic agents].
    Kisin IE, Sinitsyn LN.
    Vestn Akad Med Nauk SSSR; 1963 Oct; 18(1):18-23. PubMed ID: 4386819
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.